10-Q/A: CIMG Inc. Faces Delisting Amidst Revenue Collapse

Sentiment:

Quarterly Report Amendment


CIMG Inc. reported a 97.63% revenue decline and ongoing Nasdaq delisting threats, despite a reduced net loss and strategic pivot to Asian consumer products.

Delay expectedThe company did not timely file its Annual Report on Form 10-K for the period ended September 30, 2024, receiving a Nasdaq notice on January 17, 2025.The company did not timely file its Quarterly Report on Form 10-Q for the period ended December 31, 2024, receiving a Nasdaq notice on February 19, 2025.The company did not timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025, receiving a Nasdaq notice on May 19, 2025.The company failed to file its Form 10-K for the fiscal year ended September 30, 2024, by the extended deadline of June 13, 2025, leading to a Nasdaq delist determination letter on June 27, 2025.
Capital raiseOn August 20, 2024, the company entered into a convertible note purchase agreement for $1,300,000, which was converted into 1,396,813 shares of Common Stock by October 31, 2024.On September 24, 2024, the company entered into a securities purchase agreement for $2,000,000, resulting in the sale and issuance of 3,508,769 shares of common stock.On December 24, 2024, the company issued 800,000 shares of common stock for a total value of $523,680 under the 2024 Equity Incentive Plan.Subsequent to the reporting period, on December 12, 2024, the company entered into a Convertible Note and Warrant Purchase Agreement for $10,000,000, which led to the issuance of 19,457,618 shares of common stock on March 18, 2025, after shareholder approval.Subsequent to the reporting period, on June 2, 2025, the company entered into a Share Purchase Agreement for $1,068,480, resulting in the issuance of 6,000,000 shares of common stock on June 9, 2025.The company explicitly states its intention to seek to raise additional capital, including through public or private equity offerings, to support its operating activities for the next twelve months and beyond.
Worse than expectedRevenue for the three months ended December 31, 2024, decreased by a staggering 97.63% compared to the prior-year period, indicating a near-total collapse of the previous business model's sales.The company received a Nasdaq delist determination letter on June 27, 2025, with trading suspension scheduled for July 9, 2025, due to multiple listing deficiencies, including late filings and minimum bid price.Management concluded that internal control over financial reporting was not effective as of December 31, 2024, highlighting significant operational and governance weaknesses.The company's cash balance of $124,715 as of December 31, 2024, and accumulated deficit of $83.88 million raise substantial doubt about its ability to continue as a going concern.

Summary

  • CIMG Inc. (formerly Nuzee, Inc.) has shifted its business focus from specialty coffee to a broader range of consumer food and beverage products in Asia, particularly the 'Maca Series'.
  • Revenue for the three months ended December 31, 2024, plummeted by 97.63% to $22,853, compared to $965,932 in the same period of 2023, primarily due to the reduction in sales of original coffee products.
  • Despite the drastic revenue drop, the company's net loss decreased by 28.50% to $1,536,249 for the three months ended December 31, 2024, from $2,148,611 in the prior year, driven by significant reductions in product costs, storage, employee compensation, and professional service fees.
  • Gross profit margin significantly improved to 67.73% for the three months ended December 31, 2024, compared to 12.89% in the prior-year period, attributed to cost reductions from new product introductions.
  • The company faces multiple Nasdaq listing deficiencies, including minimum bid price, late filing of its Annual Report on Form 10-K for September 30, 2024, and Quarterly Reports on Form 10-Q for December 31, 2024, and March 31, 2025.
  • CIMG Inc. received a Nasdaq delist determination letter on June 27, 2025, for failing to file its Form 10-K by the extended deadline, with trading suspension set for July 9, 2025, unless an appeal is filed by July 7, 2025.
  • Management concluded that the company's internal control over financial reporting was not effective as of December 31, 2024.
  • The company's cash balance as of December 31, 2024, was $124,715, and it has an accumulated deficit of approximately $83.88 million, raising substantial doubt about its ability to continue as a going concern.
  • Subsequent to the reporting period, CIMG Inc. completed significant capital raises, including a $10,000,000 convertible note and warrant agreement (converted to 19,457,618 shares) and a $1,068,480 share purchase agreement (6,000,000 shares).
  • The company also completed the acquisition of 51% equity interests in Shanghai Huomao Cultural Development Co., Ltd. and Xilin Online (Beijing) E-commerce Co., Ltd. in March and April 2025, respectively, as part of its Asia expansion strategy.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to a catastrophic revenue decline, imminent Nasdaq delisting, acknowledged ineffective internal controls, and significant going concern doubts. While net loss decreased and equity turned positive due to capital raises, these are overshadowed by fundamental operational and governance failures. The strategic pivot is too early to assess positively.

Positives

  • Net loss decreased by 28.50% to $1,536,249 for the three months ended December 31, 2024, compared to the prior year.
  • Gross profit margin significantly improved to 67.73% for the three months ended December 31, 2024, up from 12.89% in the same period of 2023, due to cost reductions from new products.
  • Operating expenses decreased by 29.26% to $1,517,758 for the three months ended December 31, 2024, driven by lower warehousing, labor, and professional service costs.
  • Stockholders' equity turned positive, reaching $1,527,570 as of December 31, 2024, compared to a deficit of $(650,668) as of September 30, 2024, largely due to recent equity issuances.
  • The Curtin Litigation, a former employee lawsuit, was settled for $125,000 on November 8, 2024, and dismissed on January 22, 2025, resolving a contingent liability.
  • The company successfully raised significant capital through convertible notes and private placements subsequent to the reporting period, totaling over $11 million, which has improved its capital resources.
  • Strategic acquisitions of 51% equity interests in Shanghai Huomao Cultural Development Co., Ltd. and Xilin Online (Beijing) E-commerce Co., Ltd. were completed in March and April 2025, expanding the company's presence in the China market.

Negatives

  • Revenue for the three months ended December 31, 2024, decreased by 97.63% to $22,853 from $965,932 in the prior-year period, indicating a near-total collapse of the previous business model's sales.
  • The company had a cash balance of only $124,715 as of December 31, 2024, and an accumulated deficit of approximately $83.88 million, raising substantial doubt about its ability to continue as a going concern.
  • CIMG Inc. is not in compliance with multiple Nasdaq listing rules, including the minimum bid price requirement and timely filing of its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
  • The company received a Nasdaq delist determination letter on June 27, 2025, with trading suspension scheduled for July 9, 2025, if an appeal is not successfully made by July 7, 2025.
  • Management concluded that the company's internal control over financial reporting was not effective as of December 31, 2024, indicating significant governance weaknesses.
  • Two legal proceedings, the Kim Litigation and the Ex-Directors Lawsuit, are ongoing, posing potential financial liabilities and operational distractions.
  • The company's shift to the 'Maca Series' products is still in early stages of channel expansion, and current revenue from this new line is minimal, not yet offsetting the decline in the previous business.

Risks

  • Ability to obtain funding for operations, including necessary capital to develop, manufacture, and commercialize products, provide co-packing services, and continue as a going concern.
  • Need for additional capital to fund planned operations beyond the next twelve months from December 31, 2024.
  • Accuracy of estimates regarding expenses, future revenue, capital requirements, and needs for additional financing.
  • Ability to maintain compliance with the listing requirements of the Nasdaq Capital Market, including minimum bid price and timely filing requirements.
  • Impact of changes in general economic, business, and political conditions, including financial markets and macroeconomic conditions, on the business and supply chain.
  • Evolving coffee preferences of consumers in North America and East Asia.
  • Size and growth of the markets for products and co-packing services.
  • Ability to compete with companies producing similar products or providing similar co-packing services.
  • Ability to successfully achieve the anticipated results of strategic transactions, such as the pivot to the Maca Series and acquisitions.
  • Reliance on third-party roasters or manufacturing partners to roast coffee beans and fulfill co-packing services.
  • Regulatory developments in the U.S. and non-U.S. countries.
  • Ability to retain key management, sales, and marketing personnel.
  • Scope of protection for intellectual property rights covering products and technology.
  • Ability to develop and maintain corporate infrastructure, including internal control over financial reporting.
  • Outcome of pending, threatened, or future litigation, including the Kim Litigation and Ex-Directors Lawsuit.
  • Overall financial performance and ability to achieve profitability.
  • Effective use of net proceeds from recent offerings.
  • Potential for significant dilution to stockholders from future equity financings.

Future Outlook

The company expects to need additional capital to fund its planned operations for at least twelve months from December 31, 2024, and beyond. It plans to actively expand distribution channels and increase product launch activities for its new Maca Series products to establish a stronger foundation for revenue growth. The company intends to seek additional capital through public or private equity offerings and is working to regain compliance with Nasdaq listing requirements, including appealing the delisting determination.

Management Comments

  • "We do not expect the revenue for the three months ending December 31, 2024 to predict future quarters, as the maca product line was still in the process of new channel expansion in the December quarter, and sales revenue declined in the December quarter."
  • "Management has evaluated the Companys ability to continue as a going concern... and concluded that no substantial doubt exists regarding the Companys ability to continue as a going concern for at least one year from the date of issuance of these consolidated financial statements."

Industry Context

CIMG Inc.'s strategic pivot from its struggling specialty coffee business (Nuzee, DRIPKIT) to a broader range of consumer food and beverage products, particularly the 'Maca Series' in Asia, reflects an attempt to capitalize on the growing health and wellness trend, especially in Asian markets. This shift aligns with consumer demand for functional beverages and natural ingredients. However, the significant revenue decline indicates a challenging transition, suggesting the previous business was severely underperforming, and the new ventures are still nascent and have not yet gained substantial market traction to offset the losses.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control DeficiencyManagement concluded that the company's internal control over financial reporting was not effective as of December 31, 2024.2024-12-31This indicates a significant weakness in the company's financial reporting processes, increasing the risk of material misstatements and potentially impacting investor confidence and regulatory compliance.

Legal Proceedings

  • **Curtin Litigation**: A former employee lawsuit alleging harassment, discrimination, retaliation, and wrongful termination was settled for $125,000 on November 8, 2024, and dismissed in its entirety on January 22, 2025.
  • **Kim Litigation**: Mr. Sooncha Kim filed a complaint on October 3, 2024, alleging breach of a Convertible Note and Warrant Purchase Agreement, seeking specific performance and $1,041,216 in monetary damages. A motion for preliminary injunction was denied on February 13, 2025, and discovery is ongoing. The company believes it has a strong basis to defend the claims.
  • **Ex-Directors Lawsuit**: Former directors filed a complaint on March 10, 2025, seeking over $200,000 for unpaid directors' fees and expenses. The company's answer was due April 16, 2025, and a request for entry of default was filed on April 17, 2025, though no default has been entered. Negotiations are ongoing.

Related Party Transactions

  • As of December 31, 2024, the directors of Wewin Technology LLC paid an administrative fee of $18,000 on behalf of CIMG INC., which the company expects to clear and repay before September 30, 2025.

Stakeholder Impact

  • **Shareholders**: Face significant dilution from recent and planned equity capital raises. The ongoing Nasdaq delisting threat poses a severe risk to the liquidity and value of their investment. Ineffective internal controls also raise concerns about financial transparency and reliability.
  • **Employees**: Uncertainty due to the company's 'going concern' doubt and strategic shift, although reduced labor remuneration was a factor in decreased operating expenses.
  • **Customers**: Those of the former coffee business are impacted by its discontinuation. Customers for the new Maca Series products may see new offerings, but the nascent stage of this business implies potential supply chain or product availability risks.
  • **Creditors**: The company's 'going concern' doubt and reliance on future capital raises present elevated credit risk, although recent capital raises have temporarily improved liquidity.
  • **Management**: Faces immense pressure to resolve Nasdaq compliance issues, stabilize the new business, and secure additional funding to ensure the company's survival.

Next Steps

  • File the Annual Report on Form 10-K for the fiscal year ended September 30, 2024, as soon as possible, and in any event before July 7, 2025.
  • Appeal Nasdaq's delist determination and request a hearing before a Nasdaq Hearings Panel by July 7, 2025.
  • Continue expanding distribution channels and increasing product launch activities for the Maca Series products.
  • Seek to raise additional capital through equity, equity-linked, or debt financings to fund operations for the next twelve months and beyond.
  • Address the ongoing Kim Litigation and Ex-Directors Lawsuit.

Key Dates

DateDescription
2011Company inception.
2014-05-01FASB issued Accounting Standards Update No. 2014-09 (Topic 606) Revenue from Contracts with Customers.
2016-02-01FASB issued ASU No. 2016-02, Leases (Topic 842).
2018-06-01FASB issued ASU 2018-07 simplifying accounting for non-employee share-based transactions.
2018-10-01Company adopted Topic 606 (Revenue from Contracts with Customers).
2019-10-01Company implemented ASU No. 2016-02 (Leases) and ASU 2018-07 (Share-based payments).
2020-06-01Company listed on Nasdaq.
2020-08-01FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entitys Own Equity (Subtopic 815-40).
2021-03-01Company sold Series A and Series B warrants in an underwritten registered public offering.
2021-11-15Leased a new larger office and manufacturing space in Seoul, Korea.
2022-05-01Company renewed office and manufacturing space in Vista, California, and leased an additional 1,796 square feet.
2023-01-06Rosalina Curtin filed a complaint against the Company and Jose Ramirez in Superior Court of California.
2023-09-30End of fiscal year for which former directors claim unpaid fees and expenses.
2023-11-15Lease term ended for office and manufacturing space in Seoul, Korea.
2023-12-22Court compelled Curtin litigation to arbitration with the American Arbitration Association.
2024-02-15Social E-commerce Co., Ltd. provided a short-term, interest-free loan to the Company.
2024-04-18SOONCHA KIM lent the company $320,000 with an annual interest rate of 7%.
2024-06-06Date of Convertible Note and Warrant Purchase Agreement between the Company and Mr. Kim, subject of Kim Litigation.
2024-06-07Company's board of directors passed a resolution to sell NuZee KOREA Ltd and NuZee Investment Co., Ltd (discontinued operations).
2024-07-01Form S-1 became effective for shares of common stock issuable upon exercise of warrants.
2024-08-20Company entered into a convertible note purchase agreement with investors for $1,300,000 (August Notes).
2024-08-31Lease term ends for principal office space in Delray Beach, Florida.
2024-09-01Company leased a principal office space located at 16097 Poppyseed Cir, Unit 1904, Delray Beach, Florida.
2024-09-24Company entered into a securities purchase agreement with investors for $2,000,000.
2024-09-30End of fiscal year for which Annual Report on Form 10-K was due.
2024-10-01Company changed its corporate name to CIMG Inc. and ticker symbol to IMG.
2024-10-03Mr. Sooncha Kim filed a complaint against the Company in the Southern District of New York (Kim Litigation).
2024-10-18Holders of warrants exercised cashless option to purchase 55,973 shares of common stock.
2024-10-22Holders of warrants exercised cashless option to purchase 55,973 shares of common stock.
2024-10-31Conversion of August Notes into 1,396,813 shares of Common Stock completed.
2024-11-08Company entered into a settlement agreement with Ms. Curtin for $125,000.
2024-12-03Company filed its answer to the Kim Litigation complaint.
2024-12-12Company entered into a Convertible Note and Warrant Purchase Agreement for $10,000,000 (subsequent event).
2024-12-17Lease term ends for office space in San On Street, Tuen Mun, Hong Kong.
2024-12-18Lease term begins for office space in San On Street, Tuen Mun, Hong Kong.
2024-12-24Company issued 800,000 shares of common stock for $523,680 under the 2024 Equity Incentive Plan.
2024-12-31End of the quarterly period covered by this report.
2025-01-07Mr. Kim filed a motion seeking a preliminary injunction against the Company.
2025-01-14Company received Nasdaq Minimum Bid Price Notice.
2025-01-16Closing of the sale of notes and warrants from the December 12, 2024 agreement.
2025-01-17Company received Nasdaq Annual Report Notice for late 10-K filing.
2025-01-22Curtin case dismissed in its entirety. Company opposed Mr. Kim's motion for preliminary injunction.
2025-02-10Company obtained shareholder approval for the issuance of shares underlying the December 12, 2024 notes and warrants.
2025-02-13Court denied Mr. Kim's motion for preliminary injunction.
2025-02-19Company received Nasdaq notice for late filing of Form 10-Q for December 31, 2024.
2025-03-10Former directors filed a complaint against the Company (Ex-Directors Lawsuit). Zhongyan Shangyue Technology Co., Ltd. entered into a Business Cooperation Intent Agreement with Shanghai Huomao Cultural Development Co., Ltd.
2025-03-18Company submitted a Nasdaq compliance plan. Investors submitted conversion notices for December 12, 2024 notes, resulting in issuance of 19,457,618 shares.
2025-03-21Zhongyan Shangyue Technology Co., Ltd. established Henan Zhongyan Shangyue Technology Co. Ltd.
2025-03-27Zhongyan Shangyue Technology Co., Ltd. entered into a Business Cooperation Intent Agreement with Xilin Online (Beijing) E-commerce Co., Ltd.
2025-03-31Company completed its acquisition of Beijing Xilin.
2025-03-31Lease for office and manufacturing space in Vista, California, expires.
2025-04-16Company's answer to the Ex-Directors Lawsuit complaint was due.
2025-04-17Ex-Directors filed a request for entry of default.
2025-04-22Company completed its acquisition of Shanghai Huomao.
2025-05-19Company received Nasdaq Quarterly Report Notice for late filing of Form 10-Q for March 31, 2025.
2025-06-02Share Purchase Agreement for $1,068,480 for 6,000,000 shares of common stock (subsequent event).
2025-06-03Company submitted an update to its Nasdaq compliance plan.
2025-06-09Closing of the sale of 6,000,000 shares of common stock from the June 2, 2025 agreement.
2025-06-13Deadline for filing Form 10-K for September 30, 2024, which the company did not meet.
2025-06-27Company received Nasdaq Delist Determination Letter.
2025-07-07Deadline for the company to request an appeal of Nasdaq's delist determination.
2025-07-09Scheduled date for trading suspension of the company's common stock from Nasdaq if no appeal is made.
2025-07-14Deadline to regain compliance with Nasdaq minimum bid price requirement. Also, deadline to file Form 10-Q for December 31, 2024.
2025-08-19Number of common stock outstanding was 36,397,418 shares.
2025-08-26Original Filing date of the Quarterly Report on Form 10-Q for the quarter ended December 31, 2024.
2025-09-30Expected date for repayment of related-party administrative fee.
2025-11-18Date of this Amendment No. 1 to the Quarterly Report on Form 10-Q/A.

Recommendation

strong sell

The company faces an imminent delisting from Nasdaq, a catastrophic 97.63% decline in revenue from continuing operations, and acknowledged 'substantial doubt' about its ability to continue as a going concern. Furthermore, management has declared internal controls over financial reporting as ineffective. While recent capital raises have temporarily bolstered the balance sheet and reduced the net loss, these are overshadowed by fundamental operational failures, severe governance issues, and the high probability of losing its public listing. The strategic pivot to Maca products is too early and too small to mitigate these severe risks. A seasoned investor would view this as an extremely high-risk situation with significant downside potential.

Keywords

CIMG Inc., IMG, Nasdaq delisting, Quarterly Report, Financial Results, Maca Series, Consumer Products, Asia Expansion, Going Concern, Capital Raise, Legal Proceedings, Internal Controls, Revenue Decline, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.